Prevention of respiratory syncytial virus infection in infants: Palivizumab is effective but too expensive, and vaccines are unavailable as yet

Affordable Access

Prevention of respiratory syncytial virus infection in infants: Palivizumab is effective but too expensive, and vaccines are unavailable as yet

Publisher
BMJ Publishing Group Ltd.
Publication Date
Source
PMC
Keywords
  • Editorials
Disciplines
  • Medicine

Abstract

Statistics

Seen <100 times